Bristol Myers Squibb

Martina Miteva

Where scientific precision meets enterprise transformation, Martina Miteva brings clarity, speed and strategic value to life sciences innovation. A biomedical engineer by training, Miteva holds a master’s degree from Vanderbilt University and a bachelor's degree from the University of Washington, where she was recognized as both a NASA Space Grant Scholar and an IBM Graduate Fellow. Her foundation in translational research has shaped a career focused on bridging science and systems.

Miteva’s leadership spans roles at EY, CGI and now Bristol Myers Squibb, where she serves as Director of Research Business Insights and technology. In this role, she leads digital initiatives, accelerating R&D innovation by combining scientific insight with enterprise technology. Her work improves decision-making, enhances operational agility and strengthens data and discovery connections. Known as a trusted adviser, Miteva helps life sciences organisations unlock measurable value through targeted business and digital transformation. She delivers solutions that drive lasting impact by aligning strategic priorities with deep industry expertise.

Shaping Scientific Progress through Connected Research

True innovation doesn’t stem from discovery alone in pharmaceutical R&D—it hinges on how well systems, data and strategy support discoveries. At Bristol Myers Squibb, Miteva is driving this principle forward. As product owner for research instrument operations and data management, she is upgrading infrastructure and transforming how research teams interact with their tools, data and each other across a global footprint.

Her work is grounded in a simple yet powerful belief— breakthrough science requires environments that provide clarity, not complexity. From early-stage discovery to clinical trial design, she enables research teams to quickly analyze results, identify promising directions and make real-time data-backed decisions. By eliminating data silos and building connected lab ecosystems, she aligns research operations with strategic priorities. Integrating instrument operations and analytics into daily workflows empowers scientists to act precisely and confidently.

This isn’t digital transformation for its own sake. Every change Miteva implements serves a purpose that is accelerating insight, improving reproducibility and maximizing scientific impact.

Translating Strategy into Action across the Pharma Value Chain

Miteva’s ability to lead change stems from a rare blend of scientific depth and business acumen. Before joining Bristol Myers Squibb, she was Director of Consulting Services at CGI, where she led global cross-functional teams through large-scale transformations spanning R&D, clinical operations, quality, manufacturing and lab systems. Her strength is moving beyond high-level strategy to operational execution—partnering with stakeholders to identify bottlenecks, architecting tailored solutions and aligning actions with long-term business goals.

Whether modernizing quality systems, streamlining workflows or enabling end-to-end data integration, her focus remains the same; solving root problems and delivering measurable outcomes. Her academic background in biomedical engineering and early research at Vanderbilt University gives her a sharp understanding of science's technical and translational sides. That foundation fuels her ability to turn complex challenges into strategic opportunities.

Building Long-Term Value through Capability and Insight

What sets Miteva apart is what she builds and how she creates it. Her approach is designed for scale, sustainability and adaptability. She focuses on building internal capabilities—ensuring that systems are effective today and continue to evolve with business needs.

For every team she supports, whether internal or client-facing, the goal remains consistent¬—enabling agility, reducing time to market and driving smarter, faster decisions powered by connected, meaningful insights. Her work helps research organizations shift from fragmented processes to fully integrated ecosystems, turning transformation into a strategic advantage.